The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Suppresses NF-κB Activation and NF-κB-regulated Gene Products Through Modulation of p65 and IκBα Kinase Activation, Leading to Potentiation of Apoptosis Induced by Cytokine and Chemotherapeutic Agents
Open accessAbstract
Plumbagin, derived from the medicinal plant Plumbago zeylanica, modulates cellular proliferation, carcinogenesis, and radioresistance, all known to be regulated by the activation of the transcription factor NF-kappaB, suggesting plumbagin might affect the NF-kappaB activation pathway. We found that plumbagin inhibited NF-kappaB activation induced by TNF, and other carcinogens and inflammatory stimuli (e.g. phorbol 12-myristate 13-acetate, H2O2, cigarette smoke condensate, interleukin-1beta, lipopolysaccharide, and okadaic acid). Plumbagin also suppressed the constitutive NF-kappaB activation in certain tumor cells. The suppression of NF-kappaB activation correlated with sequential inhibition of the tumor necrosis factor (TNF)-induced activation of IkappaBalpha kinase, IkappaBalpha phosphorylation, IkappaBalpha degradation, p65 phosphorylation, p65 nuclear translocation, and the NF-kappaB-dependent reporter gene expression activated by TNF, TNFR1, TRAF2, NIK, IKK-beta, and the p65 subunit of NF-kappaB. Plumbagin also suppressed the direct binding of nuclear p65 and recombinant p65 to the DNA, and this binding was reversed by dithiothreitol both in vitro and in vivo. However, plumbagin did not inhibit p65 binding to DNA when cells were transfected with the p65 plasmid containing cysteine 38 mutated to serine. Plumbagin down-regulated the expression of NF-kappaB-regulated anti-apoptotic (IAP1, IAP2, Bcl-2, Bcl-xL, cFLIP, Bfl-1/A1, and survivin), proliferative (cyclin D1 and COX-2), and angiogenic (matrix metalloproteinase-9 and vascular endothelial growth factor) gene products. This led to potentiation of apoptosis induced by TNF and paclitaxel and inhibited cell invasion. Overall, our results indicate that plumbagin is a potent inhibitor of the NF-kappaB activation pathway that leads to suppression of NF-kappaB-regulated gene products. This may explain its cell growth modulatory, anticarcinogenic, and radiosensitizing effects previously described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Wang, C.-Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V., & Baldwin, A. S. (1998) · Science · doi:10.1126/science.281.5383.1680 · Cited by 2,711
Hsu, H., Shu, H.-B., Pan, M.-G., & Goeddel, D. V. (1996) · Cell · doi:10.1016/s0092-8674(00)80984-8 · Cited by 1,998
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Self-citationNF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Natarajan, K., Singh, S., Burke, T. R., Grunberger, D., & Aggarwal, B. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9090 · Cited by 1,139
Self-citationNuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
Self-citationEnhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Chu, Z.-L., McKinsey, T. A., Liu, L., Gentry, J. J., Malim, M. H., & Ballard, D. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10057 · Cited by 872
Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31315 · Cited by 647
NF-κB Inducers Upregulate cFLIP, a Cycloheximide-Sensitive Inhibitor of Death Receptor Signaling
Kreuz, S., Siegmund, D., Scheurich, P., & Wajant, H. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.12.3964-3973.2001 · Cited by 583
Tamatani, M., Che, Y. H., Matsuzaki, H., Ogawa, S., Okado, H., Miyake, S.-I., Mizuno, T., & Tohyama, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8531 · Cited by 549
Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer
Catz, S. D., & Johnson, J. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204926 · Cited by 538
Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras
Mayo, M. W., Wang, C.-Y., Cogswell, P. C., Rogers-Graham, K. S., Lowe, S. W., Der, C. J., & Baldwin, A. S. (1997) · Science · doi:10.1126/science.278.5344.1812 · Cited by 533
Aggarwal, S., Ichikawa, H., Takada, Y., Sandur, S. K., Shishodia, S., & Aggarwal, B. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.017400 · Cited by 532
Self-citationThioredoxin Reductase Is Irreversibly Modified by Curcumin
Fang, J., Lu, J., & Holmgren, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414645200 · Cited by 521
Takada, Y., Mukhopadhyay, A., Kundu, G. C., Mahabeleshwar, G. H., Singh, S., & Aggarwal, B. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212389200 · Cited by 495
Self-citationNuclear transcription factor-κB as a target for cancer drug development
Garg, A., & Aggarwal, B. (2002) · Leukemia · doi:10.1038/sj.leu.2402482 · Cited by 441
Self-citationShishodia, S., Majumdar, S., Banerjee, S., & Aggarwal, B. B. (2003) · PubMed · Cited by 426
Self-citationCysteine 38 in p65/NF-κB Plays a Crucial Role in DNA Binding Inhibition by Sesquiterpene Lactones
Garcı́a-Piñeres, A. J., Castro, V., Mora, G., Schmidt, T. J., Strunck, E., Pahl, H. L., & Merfort, I. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101985200 · Cited by 407
Grumont, R. J., Rourke, I. J., & Gerondakis, S. (1999) · Genes & Development · doi:10.1101/gad.13.4.400 · Cited by 403
Kapahi, P., Takahashi, T., Natoli, G., Adams, S. R., Chen, Y., Tsien, R. Y., & Karin, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007204200 · Cited by 359
Role of collagenases in tumor cell invasion
Liotta, L. A., Thorgeirsson, U. P., & Garbisa, S. (1982) · Cancer and Metastasis Review · doi:10.1007/bf00124213 · Cited by 336
Cytotoxic Action of Juglone and Plumbagin: A Mechanistic Study Using HaCaT Keratinocytes
Inbaraj, J. J., & Chignell, C. F. (2004) · Chemical Research in Toxicology · doi:10.1021/tx034132s · Cited by 335
Finco, T. S., Beg, A. A., & Baldwin, A. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11884 · Cited by 299
Giri, D. K., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.14008 · Cited by 299
Self-citationAnto, R. J. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1511 · Cited by 279
Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit
Sigala, J. L. D., Bottero, V., Young, D. B., Shevchenko, A., Mercurio, F., & Verma, I. M. (2004) · Science · doi:10.1126/science.1098387 · Cited by 219
Takada, Y., & Aggarwal, B. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3278 · Cited by 212
Self-citationPlumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cells
Srinivas, P., Gopinath, G., Banerji, A., Dinakar, A., & Srinivas, G. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20031 · Cited by 188
Estève, P. O., Chicoine, É., Robledo, O., Aoudjit, F., Descoteaux, A., Potworowski, E. F., & St-Pierre, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108600200 · Cited by 187
Tilak, J. C., Adhikari, S., & Devasagayam, T. P. A. (2004) · Redox Report · doi:10.1179/135100004225005976 · Cited by 176
You, M., Ku, P.-T., Hrdličková, R., & Bose, H. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7328 · Cited by 176
Takada, Y., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m304546200 · Cited by 169
Self-citationNasuhara, Y., Adcock, I. M., Catley, M., Barnes, P. J., & Newton, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19965 · Cited by 162
Bonizzi, G., Piette, J. G., Merville, M. P., & Bours, V. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5264 · Cited by 142
Inhibition of Nox-4 activity by plumbagin, a plant-derived bioactive naphthoquinone
Ding, Y., Chen, Z., Liu, S., Che, D., Vetter, M. L., & Chang, C. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357055119 · Cited by 128
Chaturvedi, M., LaPushin, R., & Aggarwal, B. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36662-0 · Cited by 120
Self-citationMahon, T., & O'Neill, L. A. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28557 · Cited by 117
Takada, Y., Khuri, F. R., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400963200 · Cited by 113
Self-citationZhu, L., Fukuda, S., Cordis, G. A., Das, D. K., & Maulik, N. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)03084-8 · Cited by 108
Bharti, A. C., Takada, Y., Shishodia, S., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308062200 · Cited by 104
Self-citationActivation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes.
Chen, X., Shen, B., Xia, L., Khaletzkiy, A., Chu, D. T. W., Wong, J. Y. C., & Li, J. J. (2002) · PubMed · Cited by 102
Eight 1,4-naphthoquinones from Juglans
Binder, R. G., Benson, M. E., & Flath, R. A. (1989) · Phytochemistry · doi:10.1016/s0031-9422(00)98092-0 · Cited by 93
Liang, M., Bardhan, S., Pace, E. A., Rosman, D. S., Beutler, J. A., Porco, J. A. J., & Gilmore, T. D. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.013 · Cited by 87
Ichikawa, H., Takada, Y., Murakami, A., & Aggarwal, B. B. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7383 · Cited by 85
Self-citationShrivastava, A., & Aggarwal, B. B. (1999) · Antioxidants and Redox Signaling · doi:10.1089/ars.1999.1.2-181 · Cited by 65
Self-citationNiosomal Plumbagin with Reduced Toxicity and Improved Anticancer Activity in BALB/C Mice
Naresh, R. A. R., Udupa, N., & Devi, P. U. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb03907.x · Cited by 59
Jaiswal, A. S., Bloom, L. B., & Narayan, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205789 · Cited by 48
Gopala, S., Annab, L. A., Gopinath, G., Banerji, A., & Srinivas, P. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10164 · Cited by 47
Cited by
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Self-citationProtein Lysine Acetylation by p300/CBP
Dancy, B. M., & Cole, P. A. (2015) · Chemical Reviews · doi:10.1021/cr500452k · Cited by 609
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
NF-κB and cancer: how intimate is this relationship
Prasad, S., Ravindran, J., & Aggarwal, B. B. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0267-2 · Cited by 385
Self-citationSethi, G., Ahn, K. S., Pandey, M. K., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-10-050807 · Cited by 336
Self-citation
Metadata
- Authors
- Sandur, S. K., Ichikawa, H., Sethi, G., Ahn, K. S., & Aggarwal, B. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-06
- Volume
- 281
- Issue
- 25
- Pages
- 17023-17033
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2076038104
- Cited by
- 322
- References
- 53
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.